EPISODE · Oct 28, 2025 · 23 MIN
Tregs: The Peacekeepers of Immunity
from The Allergist · host CSACI
“The immune system generally likes to be a well-balanced machine. It’s kind of like Goldilocks — too much is no good, too little is no good, and it’s finding that balance.” Dr. Vy KimTregs have been called therapists, peacekeepers, and now—thanks to this year’s Nobel Prize—front-page immunology. Dr. Vy Kim joins Dr. Mariam Hanna to unpack why these cells might hold the key to everything from tolerance to therapy response, and what allergists should be watching for next.How Tregs bridge central and peripheral tolerance—and why that matters in allergy.What their dysfunction reveals about the origins of allergic disease.Why allergen-specific Tregs could signal immunotherapy success.How far we are from clinical testing and therapeutic manipulation.What “Goldilocks” balance really looks like inside the immune system.The unanswered questions that will shape the future of Treg-based interventions.It’s not every day the Nobel Prize lines up with what’s happening in your clinic. This is one of those days.Have an idea for the show or a comment, send us a text!Visit the Canadian Society of Allergy and Clinical ImmunologyFind an allergist using our helpful toolFind Dr. Hanna on X, previously Twitter, @PedsAllergyDoc or CSACI @CSACI_caThe Allergist is produced for CSACI by PodCraft Productions
What this episode covers
“The immune system generally likes to be a well-balanced machine. It’s kind of like Goldilocks — too much is no good, too little is no good, and it’s finding that balance.” Dr. Vy Kim Tregs have been called therapists, peacekeepers, and now—thanks to this year’s Nobel Prize—front-page immunology. Dr. Vy Kim joins Dr. Mariam Hanna to unpack why these cells might hold the key to everything from tolerance to therapy response, and what allergists should be watching for next. How Tregs bridg...
NOW PLAYING
Tregs: The Peacekeepers of Immunity
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m